カテゴリー： P&S Market Research, 世界, 医療/バイオ

生体電気医療のグローバル市場：エンドユーザー別、用途別、デバイス種類別、製品別

◆英語タイトル：Bioelectric Medicine Market Share Analysis by End User (Hospitals, Clinics, Ambulatory Surgery Centers), Application (Arrhythmia, Pain Management, Parkinson’s Disease, Depression, Ischemia, Epilepsy), Device Type (Implantable, Non-Invasive), Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Spinal Cord Stimulators, Cochlear Implants, Deep-Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Retinal Implants) - Global Industry Growth and Demand Forecast to 2030

P&S Market Researchが発行した調査報告書（PS23SEP044）◆商品コード：PS23SEP044
◆発行会社（リサーチ会社）：P&S Market Research
◆発行日：2023年2月
   最新版(2025年又は2026年)はお問い合わせください。
◆ページ数：240
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

P&S Intelligence社の最新レポートによると、2022年の生体電気医療市場規模は215億3,210万ドルで、今後5.2%のペースで拡大し、2030年には323億4,580万ドルに達する見込みです。
最も使用されている植込み型除細動器
- 植込み型除細動器は、幅広い用途に使用できるため、すべての製品の中で最も使用されています。その電気刺激能力により、心房細動、心室頻拍、心房粗動の治療に必要です。
- さらに、薬物療法や手術など、他の治療法とも併用されます。
- 高齢者層における心停止や神経疾患の増加が、このカテゴリーの成長を後押ししています。
- このような社会では、除細動器、脳深部刺激装置、心臓ペースメーカー、脊髄刺激装置などの植え込み型装置に対する需要が高まっています。

不整脈患者で最も高い生体電気医療ニーズ
不整脈カテゴリーは売上の約60%を占め、業界を支配しています。これは、植え込み型除細動器や心臓ペースメーカーが広く使用されている不整脈患者が増加しているためです。さらに、いくつかのプレーヤーは、共同研究、合併、パートナーシップを通じて、ビジネスの見通しを増やすことに重点を置いています。

生体電気医療の需要は北米で最も高い
北米は、研究開発投資の高さ、技術的に進歩したデバイスの受容の高まり、大手プレイヤーの存在、大規模な病院数により、過去に40%以上の最大の収益シェアを占めていました。さらに、医療費の増加がこの地域の業界を牽引する重要な要因となっています。さらに、アルツハイマー病、てんかん、脊髄損傷、不整脈など、多くの健康疾患の有病率が増加していること、医療インフラに対する政府支出が増加していること、臨床ラボや新しい診断技術に広くアクセスできることから、APACが最も急成長する見込みです。

植え込み型電気治療機器の受け入れ拡大
植え込み型電気治療器カテゴリーは、過去に約80％の最大シェアを占めていました。これは主に、多くの心血管疾患や神経疾患の有病率が増加していることと、製品の承認数が増加していることによるものです。

エンドユーザーとして最も急成長する病院
病院は、今後数年間で、7％前後の急成長を遂げるでしょう。これは、神経疾患や聴覚疾患の検出と治療のための最先端機器が利用可能であることと、これらの施設に熟練した医療従事者がいるためです。例えば、アルツハイマー病、不整脈、てんかん、慢性疼痛、網膜色素変性症などのいくつかの慢性疾患は、患者の入院につながります。2022年、アルツハイマー病協会によると、65歳以上のアメリカ人は約650万人、75歳以上のアメリカ人の約73%がアルツハイマー病を患っています。

第1章．調査範囲
第2章．調査方法
第3章．エグゼクティブサマリー
第4章．産業専門家の意見/KOL
第5章．市場指標
第6章．産業動向
第7章．世界市場
第8章．北米市場
第9章．ヨーロッパ市場
第10章．アジア太平洋市場
第11章．中南米市場
第12章．中東・アフリカ市場
第13章．アメリカ市場
第14章．カナダ市場
第15章．ドイツ市場
第16章．フランス市場
第17章．イギリス市場
第18章．イタリア市場
第19章．スペイン市場
第20章．日本市場
第21章．中国市場
第22章．インド市場
第23章．オーストラリア市場
第24章．韓国市場
第25章．ブラジル市場
第26章．メキシコ市場
第27章．サウジアラビア市場
第28章．南アフリカ市場
第29章．中東市場
第30章．競争状況
第31章．企業情報
第32章．付録

❖ レポートの目次 ❖

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segment

1.4.1. Market size breakdown, by end user

1.4.2. Market size breakdown, by application

1.4.3. Market size breakdown, by device type

1.4.4. Market size breakdown, by product

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by End User (2017–2030)

7.3. Market Revenue, by Application (2017–2030)

7.4. Market Revenue, by Device Type (2017–2030)

7.5. Market Revenue, by Product (2017–2030)

7.6. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by End User (2017–2030)

8.3. Market Revenue, by Application (2017–2030)

8.4. Market Revenue, by Device Type (2017–2030)

8.5. Market Revenue, by Product (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by End User (2017–2030)

9.3. Market Revenue, by Application (2017–2030)

9.4. Market Revenue, by Device Type (2017–2030)

9.5. Market Revenue, by Product (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by End User (2017–2030)

10.3. Market Revenue, by Application (2017–2030)

10.4. Market Revenue, by Device Type (2017–2030)

10.5. Market Revenue, by Product (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by End User (2017–2030)

11.3. Market Revenue, by Application (2017–2030)

11.4. Market Revenue, by Device Type (2017–2030)

11.5. Market Revenue, by Product (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by End User (2017–2030)

12.3. Market Revenue, by Application (2017–2030)

12.4. Market Revenue, by Device Type (2017–2030)

12.5. Market Revenue, by Product (2017–2030)

12.6. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by End User (2017–2030)

13.3. Market Revenue, by Application (2017–2030)

13.4. Market Revenue, by Device Type (2017–2030)

13.5. Market Revenue, by Product (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by End User (2017–2030)

14.3. Market Revenue, by Application (2017–2030)

14.4. Market Revenue, by Device Type (2017–2030)

14.5. Market Revenue, by Product (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by End User (2017–2030)

15.3. Market Revenue, by Application (2017–2030)

15.4. Market Revenue, by Device Type (2017–2030)

15.5. Market Revenue, by Product (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by End User (2017–2030)

16.3. Market Revenue, by Application (2017–2030)

16.4. Market Revenue, by Device Type (2017–2030)

16.5. Market Revenue, by Product (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by End User (2017–2030)

17.3. Market Revenue, by Application (2017–2030)

17.4. Market Revenue, by Device Type (2017–2030)

17.5. Market Revenue, by Product (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by End User (2017–2030)

18.3. Market Revenue, by Application (2017–2030)

18.4. Market Revenue, by Device Type (2017–2030)

18.5. Market Revenue, by Product (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by End User (2017–2030)

19.3. Market Revenue, by Application (2017–2030)

19.4. Market Revenue, by Device Type (2017–2030)

19.5. Market Revenue, by Product (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by End User (2017–2030)

20.3. Market Revenue, by Application (2017–2030)

20.4. Market Revenue, by Device Type (2017–2030)

20.5. Market Revenue, by Product (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by End User (2017–2030)

21.3. Market Revenue, by Application (2017–2030)

21.4. Market Revenue, by Device Type (2017–2030)

21.5. Market Revenue, by Product (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by End User (2017–2030)

22.3. Market Revenue, by Application (2017–2030)

22.4. Market Revenue, by Device Type (2017–2030)

22.5. Market Revenue, by Product (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by End User (2017–2030)

23.3. Market Revenue, by Application (2017–2030)

23.4. Market Revenue, by Device Type (2017–2030)

23.5. Market Revenue, by Product (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by End User (2017–2030)

24.3. Market Revenue, by Application (2017–2030)

24.4. Market Revenue, by Device Type (2017–2030)

24.5. Market Revenue, by Product (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by End User (2017–2030)

25.3. Market Revenue, by Application (2017–2030)

25.4. Market Revenue, by Device Type (2017–2030)

25.5. Market Revenue, by Product (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by End User (2017–2030)

26.3. Market Revenue, by Application (2017–2030)

26.4. Market Revenue, by Device Type (2017–2030)

26.5. Market Revenue, by Product (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by End User (2017–2030)

27.3. Market Revenue, by Application (2017–2030)

27.4. Market Revenue, by Device Type (2017–2030)

27.5. Market Revenue, by Product (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by End User (2017–2030)

28.3. Market Revenue, by Application (2017–2030)

28.4. Market Revenue, by Device Type (2017–2030)

28.5. Market Revenue, by Product (2017–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by End User (2017–2030)

29.3. Market Revenue, by Application (2017–2030)

29.4. Market Revenue, by Device Type (2017–2030)

29.5. Market Revenue, by Product (2017–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and Their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. Medtronic plc

31.1.1. Business overview

31.1.2. Product and service offerings

31.1.3. Key financial summary

31.2. Abbott Laboratories

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. Boston Scientific Corporation

31.3.1. Business overview

31.3.2. Product and service offerings

31.3.3. Key financial summary

31.4. LivaNova PLC

31.4.1. Business overview

31.4.2. Product and service offerings

31.4.3. Key financial summary

31.5. Cochlear Limited

31.5.1. Business overview

31.5.2. Product and service offerings

31.5.3. Key financial summary

31.6. Nevro Corp.

31.6.1. Business overview

31.6.2. Product and service offerings

31.6.3. Key financial summary

31.7. Axonics Inc.

31.7.1. Business overview

31.7.2. Product and service offerings

31.7.3. Key financial summary

31.8. Second Sight Medical Products Inc.

31.8.1. Business overview

31.8.2. Product and service offerings

31.8.3. Key financial summary

31.9. electroCore Inc.

31.9.1. Business overview

31.9.2. Product and service offerings

31.9.3. Key financial summary

31.10. Sonova Holding AG

31.10.1. Business overview

31.10.2. Product and service offerings

31.10.3. Key financial summary

31.11. Biowave Limited

31.11.1. Business overview

31.11.2. Product and service offerings

31.12. MicroPort Scientific Corporation

31.12.1. Business overview

31.12.2. Product and service offerings

31.12.3. Key financial summary

31.13. SetPoint Medical Corporation

31.13.1. Business overview

31.13.2. Product and service offerings

31.14. Sky Medical Technology

31.14.1. Business overview

31.14.2. Product and service offerings

31.15. Neuronetics Inc.

31.15.1. Business overview

31.15.2. Product and service offerings

31.15.3. Key financial summary

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL BIOELECTRIC MEDICINE MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 15 GLOBAL BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 16 GLOBAL BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 17 GLOBAL BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 18 GLOBAL BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 19 MAJOR WORLDWIDE MARKETS FOR BIOELECTRIC MEDICINE, $M

FIG 20 NORTH AMERICA BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 21 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 22 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 23 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 24 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 25 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 26 EUROPE BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 27 EUROPE BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 28 EUROPE BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 29 EUROPE BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 30 EUROPE BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 31 EUROPE BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 32 APAC BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 33 APAC BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 34 APAC BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 35 APAC BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 36 APAC BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 37 APAC BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 38 LATAM BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 39 LATAM BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 40 LATAM BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 41 LATAM BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 42 LATAM BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 43 LATAM BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 MEA BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 45 MEA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 46 MEA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 47 MEA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 48 MEA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 49 MEA BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 50 U.S. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 51 U.S. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 52 U.S. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 53 U.S. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 54 CANADA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 55 CANADA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 56 CANADA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 57 CANADA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 58 GERMANY BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 59 GERMANY BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 60 GERMANY BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 61 GERMANY BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 62 FRANCE BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 63 FRANCE BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 64 FRANCE BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 65 FRANCE BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 66 U.K. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 67 U.K. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 68 U.K. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 69 U.K. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 70 ITALY BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 71 ITALY BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 72 ITALY BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 73 ITALY BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 74 SPAIN BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 75 SPAIN BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 76 SPAIN BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 77 SPAIN BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 78 JAPAN BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 79 JAPAN BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 80 JAPAN BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 81 JAPAN BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 82 CHINA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 83 CHINA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 84 CHINA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 85 CHINA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 86 INDIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 87 INDIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 88 INDIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 89 INDIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 90 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 91 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 92 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 93 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 94 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 95 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 96 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 97 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 98 BRAZIL BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 99 BRAZIL BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 100 BRAZIL BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 101 BRAZIL BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 102 MEXICO BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 103 MEXICO BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 104 MEXICO BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 105 MEXICO BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 106 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 107 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 108 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 109 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 110 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 111 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 112 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 113 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 114 U.A.E. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 115 U.A.E. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 116 U.A.E. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 117 U.A.E. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 118 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 119 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 120 BOSTON SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 121 LIVANOVA PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 122 COCHLEAR LIMITED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 123 NEVRO CORP. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 124 AXONICS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 125 SECOND SIGHT MEDICAL PRODUCTS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 126 ELECTROCORE INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 127 SONOVA HOLDING AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 128 MICROPORT SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 129 NEURONETICS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)


※参考情報

生体電気医療とは、人体における電気的な現象や信号を利用して、健康を維持し、病気の診断や治療を行う医療分野です。生体電気医療は、体内で自然に発生する電気信号を基にしているため、患者への侵襲が少なく、非侵襲的な治療法が多く含まれています。また、神経や筋肉の機能を調整する技術が中心であり、広範な応用可能性を持っています。
生体電気医療には、いくつかの種類があります。まず、伝導電気刺激療法が挙げられます。これは、電気的な信号を用いて神経を刺激し、筋肉の収縮を引き起こす治療法です。特に、リハビリテーションや神経障害の患者に対して効果を発揮することがあります。

次に、電気生理学的診断法があり、心臓や脳などの生理的な電気信号を観察することで、病状を診断する手法です。心電図（ECG）や脳波（EEG）などがこの典型的な例です。これにより、心筋の異常や脳の疾患を早期に発見することが可能です。

さらに、電気的誘導治療も生体電気医療に含まれます。これは、特定の周波数や波形の電気信号を体内に導入することで、細胞の再生や修復を促す技術です。たとえば、超音波や電気刺激療法によって、骨の再生を促す治療が行われています。

生体電気医療は、その用途も多岐にわたります。慢性的な痛みの緩和、筋力の回復、リハビリテーション、心疾患や脳卒中の予防・治療において重要な役割を果たしています。また、しばしば整形外科や神経科の医療現場で使われますが、美容医療やスポーツ医療にも応用されています。具体的には、筋肉の強化、皮膚の引き締め、さらには脂肪減少を目的とした治療法にも利用されています。

関連技術としては、ウェアラブルデバイスやバイオフィードバックがあり、これらは生体電気医療と密接に関係しています。特に、ウェアラブルデバイスは、体内の電気信号をリアルタイムでモニタリングすることで、健康管理に貢献します。これにより、ユーザーは自分の健康状態を把握しやすくなり、予防医療の一環としても利用されています。

また、神経インターフェースや脳-コンピュータインターフェースといった先端技術も含まれます。これらの技術は、患者の意図を電気信号に変換し、義肢や補助装置を制御する手段を提供します。特に、四肢麻痺の患者にとっては、自立した生活をサポートするための重要な手段となります。

生体電気医療は、今後ますます進化する分野であり、科学技術の発展に伴って新たな治療法や診断法の開発が期待されています。例えば、人工知能（AI）や機械学習を取り入れた解析技術により、より精度の高い診断や治療の個別化が進むことが考えられます。

生体電気医療は、今後の医療において大きな役割を果たす可能性があり、さらなる研究と開発が求められています。安全性や効果の向上に加えて、患者の生活の質を向上させる技術が進展することで、多くの人々に恩恵をもたらすと期待されています。このように、生体電気医療の重要性はますます高まってきており、我々の健康を支える新しい可能性を探求し続けることが重要です。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 生体電気医療のグローバル市場：エンドユーザー別、用途別、デバイス種類別、製品別(Bioelectric Medicine Market Share Analysis by End User (Hospitals, Clinics, Ambulatory Surgery Centers), Application (Arrhythmia, Pain Management, Parkinson’s Disease, Depression, Ischemia, Epilepsy), Device Type (Implantable, Non-Invasive), Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Spinal Cord Stimulators, Cochlear Implants, Deep-Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Retinal Implants) - Global Industry Growth and Demand Forecast to 2030)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 熱管理技術のグローバル市場：材料種類別、デバイス種類別、サービス別、エンドユーザー別
  • マルチパラメータ患者モニタリングシステムのグローバル市場：デバイス種類別、強度レベル別、年齢層別、エンドユーザー別
  • 超音波プローブカバーのグローバル市場：種類別、製品種類別、用途別、エンドユーザー別
  • PTAバルーンカテーテルのグローバル市場：素材種類別、用途別、エンドユーザー別、製品種類別
  • 使い捨てバイオリアクターのグローバル市場：製品種類別、種類別、細胞種類別、分子種類別、用途別、使用別、エンドユーザー別

    • ◆H&Iグローバルリサーチのお客様（例）◆